News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,432 Results
Type
Article (69592)
Company Profile (274)
Press Release (642566)
Section
Business (197137)
Career Advice (2854)
Deals (34973)
Drug Delivery (124)
Drug Development (84006)
Employer Resources (175)
FDA (16845)
Job Trends (14984)
News (343049)
Policy (34759)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (9)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (3)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2879)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (82)
Alliances (50870)
ALS (91)
Alzheimer's disease (1461)
Antibody-drug conjugate (ADC) (136)
Approvals (16814)
Artificial intelligence (262)
Autoimmune disease (19)
Automation (10)
Bankruptcy (339)
Best Places to Work (11253)
BIOSECURE Act (21)
Biosimilars (114)
Biotechnology (151)
Bladder cancer (62)
Brain cancer (28)
Breast cancer (258)
Cancer (2088)
Cardiovascular disease (173)
Career advice (2387)
Career pathing (33)
CAR-T (158)
Cell therapy (432)
Cervical cancer (19)
Clinical research (67498)
Collaboration (810)
Compensation (454)
Complete response letters (30)
COVID-19 (2781)
CRISPR (42)
C-suite (215)
Cystic fibrosis (100)
Data (1939)
Decentralized trials (2)
Denatured (30)
Depression (48)
Diabetes (263)
Diagnostics (6317)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (122)
Drug pricing (120)
Drug shortages (32)
Duchenne muscular dystrophy (90)
Earnings (76789)
Editorial (39)
Employer branding (23)
Employer resources (153)
Events (105764)
Executive appointments (645)
FDA (17978)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (700)
Gene editing (105)
Generative AI (23)
Gene therapy (315)
GLP-1 (803)
Government (4455)
Grass and pollen (4)
Guidances (47)
Healthcare (18468)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (124)
Indications (27)
Infectious disease (2924)
Inflammatory bowel disease (139)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (86)
Interviews (524)
IPO (16247)
IRA (49)
Job creations (4171)
Job search strategy (1999)
Kidney cancer (10)
Labor market (31)
Layoffs (516)
Leadership (20)
Legal (8451)
Liver cancer (76)
Lung cancer (311)
Lymphoma (133)
Machine learning (2)
Management (62)
Manufacturing (293)
MASH (66)
Medical device (12776)
Medtech (12781)
Mergers & acquisitions (19215)
Metabolic disorders (714)
Multiple sclerosis (74)
NASH (23)
Neurodegenerative disease (97)
Neuropsychiatric disorders (31)
Neuroscience (1978)
NextGen: Class of 2025 (6329)
Non-profit (4633)
Northern California (2390)
Now hiring (33)
Obesity (393)
Opinion (257)
Ovarian cancer (74)
Pain (84)
Pancreatic cancer (79)
Parkinson's disease (140)
Partnered (20)
Patents (212)
Patient recruitment (95)
Peanut (50)
People (57652)
Pharmaceutical (98)
Pharmacy benefit managers (21)
Phase I (20867)
Phase II (29316)
Phase III (22474)
Pipeline (1014)
Podcasts (106)
Policy (132)
Postmarket research (3011)
Preclinical (9211)
Press Release (71)
Prostate cancer (97)
Psychedelics (38)
Radiopharmaceuticals (254)
Rare diseases (392)
Real estate (6218)
Recruiting (70)
Regulatory (23945)
Reports (37)
Research institute (2626)
Resumes & cover letters (469)
Rett syndrome (3)
RNA editing (3)
RSV (44)
Schizophrenia (74)
Series A (125)
Series B (80)
Service/supplier (19)
Sickle cell disease (55)
Southern California (2047)
Special edition (18)
Spinal muscular atrophy (163)
Sponsored (33)
Startups (3643)
State (2)
Stomach cancer (16)
Supply chain (64)
The Weekly (73)
United States (21017)
Vaccines (760)
Venture capitalists (39)
Webinars (13)
Weight loss (291)
Women's health (34)
Worklife (18)
Date
Today (127)
Last 7 days (625)
Last 30 days (2633)
Last 365 days (34526)
2025 (8120)
2024 (35965)
2023 (40503)
2022 (51598)
2021 (55857)
2020 (53812)
2019 (45865)
2018 (34706)
2017 (33986)
2016 (33810)
2015 (38729)
2014 (32400)
2013 (28455)
2012 (29866)
2011 (30330)
2010 (28897)
Location
Africa (968)
Alabama (52)
Alaska (7)
Arizona (207)
Arkansas (13)
Asia (43715)
Australia (7526)
California (5428)
Canada (1792)
China (483)
Colorado (249)
Connecticut (276)
Delaware (131)
Europe (99604)
Florida (809)
Georgia (185)
Hawaii (1)
Idaho (58)
Illinois (500)
India (25)
Indiana (274)
Iowa (9)
Japan (144)
Kansas (97)
Kentucky (24)
Louisiana (7)
Maine (64)
Maryland (857)
Massachusetts (4154)
Michigan (209)
Minnesota (366)
Mississippi (1)
Missouri (72)
Montana (27)
Nebraska (24)
Nevada (53)
New Hampshire (56)
New Jersey (1585)
New Mexico (28)
New York (1575)
North Carolina (979)
North Dakota (7)
Northern California (2390)
Ohio (186)
Oklahoma (12)
Oregon (35)
Pennsylvania (1210)
Puerto Rico (10)
Rhode Island (24)
South America (1332)
South Carolina (18)
South Dakota (1)
Southern California (2047)
Tennessee (88)
Texas (800)
Utah (153)
Virginia (137)
Washington D.C. (64)
Washington State (519)
West Virginia (3)
Wisconsin (56)
712,432 Results for "apr applied pharma research s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives find themselves faced with policy questions ranging from the Inflation Reduction Act to RFK Jr.
February 12, 2025
·
4 min read
·
Annalee Armstrong
Podcasts
Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC director nominee; Novo Nordisk joins the triple-G race; Alnylam wins approval for Amvuttra in ATTR-CM; and Cassava Sciences ends development of simufilam in Alzheimer’s.
March 26, 2025
·
1 min read
·
Heather McKenzie
Press Releases
SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer
March 28, 2025
·
2 min read
Press Releases
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting
March 27, 2025
·
4 min read
COVID-19
Novavax Applies Lessons Learned From Turbulent COVID-19 Experience
As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help of the company’s pharma partners—something it opted not to do as the pandemic swept the globe in 2020.
March 10, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
March 26, 2025
·
7 min read
Podcast
Trump’s Pharma Tariffs, Another GLP-1 Compounding Lawsuit, Bluebird’s Bailout, More
As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as Eli Lilly offers expanded Zepbound options; and struggling gene therapy biotech bluebird bio goes private in an attempt to stay solvent.
February 26, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
March 12, 2025
·
9 min read
Press Releases
Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
March 26, 2025
·
8 min read
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
·
2 min read
·
Tristan Manalac
1 of 71,244
Next